The U.S. Federal Trade Commission is probing complaints about telehealth platform Hims & Hers regarding its advertising and ...

Hims & Hers first told investors about a regulatory review in July 2024, but Bloomberg's report adds new color on what ...

Hims & Hers Health (NYSE:HIMS) stock fell 4.1% in after-hours trading on Thursday following a Bloomberg report that revealed ...

Hims & Hers shares fall after a report says the FTC has investigated its cancellation policies and billing practices for over ...

After Bloomberg reported, citing people familiar with the probe, that the Federal Trade Commission has been investigating ...

Telehealth company Hims & Hers Health’s ($HIMS) business practices have been under investigation by the U.S. Federal Trade ...

For more than a year, the Federal Trade Commission has been investigating Hims & Hers Health Inc.’s business practices, including whether it has made it too hard for customers to cancel subscriptions, ...

Investing.com -- Hims & Hers Health (NYSE:HIMS) stock fell 5% in after-hours trading on Thursday following a Bloomberg report ...

The FTC has been probing Hims & Hers Health’s business practices for more than a year, including whether it has made it too hard for customers to ...

The US health sector is bustling with activity. Key developments include an FTC investigation into Hims & Hers' practices, ...

Investing.com -- Hims & Hers Health (NYSE:HIMS) stock dropped 2.6% on Friday following reports that the Federal Trade Commission has been investigating the telehealth company's business practices for ...

A draft of the Trump administration’s highly anticipated blueprint on health policy takes a softer approach to regulating companies than many had feared, a relief for industry and setback for ...